PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
12171167-4	2002	Northern blot analysis was used to quantify the expression of COX-2 in first-passage cultures of equine articular chondrocytes propagated in media containing dexamethasone (DEX), phenylbutazone (PBZ), polysulfated glycosaminoglycan, and hyaluronan, each at concentrations of 10 and 100 microg/ml and each with or without reIL-1beta.	Phenylbutazone	179-193	cytochrome c oxidase subunit II	Equus caballus	62-67	
15939622-0	2005	COX-1 and COX-2 inhibition in horse blood by phenylbutazone, flunixin, carprofen and meloxicam: an in vitro analysis.	Phenylbutazone	45-59	cytochrome c oxidase subunit II	Equus caballus	10-15	
15939622-3	2005	However at IC80, phenylbutazone (+134.4%) and flunixin (+29.7%) had greater COX-2 selectivity than at IC50, and meloxicam (-41.2%) and carprofen (-12.9%) had lower COX-2 selectivity than at IC50.	Phenylbutazone	17-31	cytochrome c oxidase subunit II	Equus caballus	76-81	
15939622-3	2005	However at IC80, phenylbutazone (+134.4%) and flunixin (+29.7%) had greater COX-2 selectivity than at IC50, and meloxicam (-41.2%) and carprofen (-12.9%) had lower COX-2 selectivity than at IC50.	Phenylbutazone	17-31	cytochrome c oxidase subunit II	Equus caballus	164-169	
12171167-4	2002	Northern blot analysis was used to quantify the expression of COX-2 in first-passage cultures of equine articular chondrocytes propagated in media containing dexamethasone (DEX), phenylbutazone (PBZ), polysulfated glycosaminoglycan, and hyaluronan, each at concentrations of 10 and 100 microg/ml and each with or without reIL-1beta.	Phenylbutazone	195-198	cytochrome c oxidase subunit II	Equus caballus	62-67